BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 32516127)

  • 21. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
    Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
    Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icariin inhibits gastric cancer cell growth by regulating the hsa_circ_0003159/miR-223-3p/NLRP3 signaling axis.
    Zhang F; Yin Y; Xu W; Song Y; Zhou Z; Sun X; Li P
    Hum Exp Toxicol; 2022; 41():9603271221097363. PubMed ID: 35532261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death.
    Liu J; Yao L; Zhang M; Jiang J; Yang M; Wang Y
    Aging (Albany NY); 2019 Sep; 11(18):7830-7846. PubMed ID: 31553952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
    Sun L; Liu L; Yang J; Li H; Zhang C
    J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.
    Tan J; Fan J; He J; Zhao L; Tang H
    J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
    Guo Q; Ni P; Dai Y; Hu J; Yao Y
    J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of miR-223 abrogates NLRP3 inflammasome-mediated pyroptosis to attenuate oxidized low-density lipoprotein (ox-LDL)-induced cell death in human vascular endothelial cells (ECs).
    Wang X; Li X; Wu Y; Song Y
    In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):670-679. PubMed ID: 32914384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis.
    Jin W; Zhang H; Li M; Lin S
    Cancer Biother Radiopharm; 2023 Mar; 38(2):122-131. PubMed ID: 32614615
    [No Abstract]   [Full Text] [Related]  

  • 31. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
    Xiao S; Song B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review on the role of ADAMTS9-AS2 in different disorders.
    Ghafouri-Fard S; Askari A; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
    Pathol Res Pract; 2023 Mar; 243():154346. PubMed ID: 36746036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.
    Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z
    Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
    Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
    Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
    Chen Z; Tang W; Ye W; Song L; Chen Z
    Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer.
    YiRen H; YingCong Y; Sunwu Y; Keqin L; Xiaochun T; Senrui C; Ende C; XiZhou L; Yanfan C
    Mol Cancer; 2017 Nov; 16(1):174. PubMed ID: 29162158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.